Left Ventricular Non-compaction Cardiomyopathy and Polycystic Kidney Disease Revealed by Inappropriate Polycythemia: A Fortuitous Association? Case Report

Left Ventricular Non-compaction Cardiomyopathy and Polycystic Kidney Disease Revealed by Inappropriate Polycythemia: A Fortuitous Association? Case Report

We present the case of a patient with heart failure with reduced left ventricular (LV) ejection fraction, diagnosed in the first instance by echocardiography and further on by more accurate cardiac magnetic resonance imaging with LV non-compaction (LVNC). Blood tests showed high erythrocyte and hema...

Full description

Bibliographic Details
Main Authors:	Hodorogea Andreea Simona, Dan Gheorghe Andrei Cristian, Pârvu Irina, Nanea Ioan Tiberiu, Gheorghe And Gabriela Silvia
Format:	Article
Language:	English
Published:	Sciendo 2023-01-01
Series:	Romanian Journal of Cardiology
Subjects:	left ventricular non-compaction autosomal dominant polycystic kidney disease polycystin polycythemia noncompactare ventriculară boala renală polichistică autosomal dominantă policistine policitemia
Online Access:	https://doi.org/10.2478/rjc-2022-0037

Similar Items

SINDROMUL POTTER, O ENTITATE RARĂ CU RISC DE RECURENŢĂ LA FEMEILE CU MALFORMAŢII RENALE – PREZENTARE DE CAZ ŞI DATE DIN LITERATURĂ
by: George Rolea, et al.
Published: (2017-06-01)

Cyst growth, polycystins, and primary cilia in autosomal dominant polycystic kidney disease
by: Seung Hun Lee, et al.
Published: (2014-06-01)

Autosomal dominant polycystic kidney disease: an update on epidemiological and molecular aspects
by: Everton F. Alves, et al.
Published: (2015-12-01)

Autosomal Dominant Polycystic Kidney Disease: Is There a Role for Autophagy?
by: Claudio Ponticelli, et al.
Published: (2023-09-01)

Aspectos psicológicos en pacientes con policitemia relativa hipovolémicos y normovolémicos Psychological aspects in hypovolemic and normovolemic patients with relative polycythemia
by: Raúl Martínez Triana, et al.
Published: (1999-08-01)

Cardiac Involvement in Autosomal Dominant Polycystic Kidney Disease
by: Letizia Spinelli, et al.
Published: (2021-04-01)

Anoctamin 1 Inhibition Suppresses Cystogenesis by Enhancing Ciliogenesis and the Ciliary Dosage of Polycystins
by: Tao Xu, et al.
Published: (2022-07-01)

Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?
by: Magdalena Jankowska, et al.
Published: (2017-05-01)

Regulation of CFTR Expression and Arginine Vasopressin Activity Are Dependent on Polycystin-1 in Kidney-Derived Cells
by: Carolina Monteiro de Lemos Barbosa, et al.
Published: (2016-01-01)

Real-Time High Resolution Melting Analysis-PCR for Assessment of Gene Mutations in Human Autosomal Dominant Polycystic Kidney Disease
by: Mohd Jas, Rusni
Published: (2011)

Interdependent Regulation of Polycystin Expression Influences Starvation-Induced Autophagy and Cell Death
by: Jean-Paul Decuypere, et al.
Published: (2021-12-01)

Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing
by: Othman R. Alzahrani, et al.
Published: (2022-11-01)

Risk Factors for Neurocognitive Functioning in Children with Autosomal Recessive Polycystic Kidney Disease
by: Stephen R. Hooper
Published: (2017-05-01)

Intracellular calcium release modulates polycystin-2 trafficking
by: Miyakawa Ayako, et al.
Published: (2013-02-01)

The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease
by: Ryo Matsuura, et al.
Published: (2017-01-01)

AUTOSOMAL – DOMINANT POLYCYSTIC KIDNEY DISEASE – A GLEAM OF HOPE?
by: V.V. Doretskyi, et al.
Published: (2014-01-01)

Tolvaptan: a possible preemptive treatment option in children with autosomal dominant polycystic kidney disease?
by: Hee Sun Beak, et al.
Published: (2023-12-01)

Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease
by: Hiroki Mizuno, et al.
Published: (2017-07-01)

Serum erythropoietin level in anemia of chronic kidney disease - experience of a Romanian medical centre / Nivelul eritropoietinei serice în anemia din boala renală cronică - experiența unui centru medical românesc
by: Pop Nicoleta Dora, et al.
Published: (2015-03-01)

Zebrafish Model as a Screen to Prevent Cyst Inflation in Autosomal Dominant Polycystic Kidney Disease
by: Inês Oliveira, et al.
Published: (2021-08-01)

Polycystic Kidney Disease–Related Disease Burden in Adolescents With Autosomal Dominant Polycystic Kidney Disease: An International Qualitative StudyPlain-Language Summary
by: Dorothee Oberdhan, et al.
Published: (2022-03-01)

Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy
by: Degli Esposti L, et al.
Published: (2017-04-01)

Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment
by: Jana Reiterová, et al.
Published: (2022-03-01)

Femoral Neuropathy Secondary to Autosomal Dominant Polycystic Kidney Disease: A Case Report
by: Jeehyun Yoo, et al.
Published: (2018-06-01)

Unraveling the Complexity of Childhood Polycystic Kidney Disease: A Case Study of Three Sisters
by: Ivana Trutin, et al.
Published: (2023-10-01)

Management of nephrolithiasis in autosomal dominant polycystic kidney disease - A single center experience
by: Ramen Baishya, et al.
Published: (2012-01-01)

Polycystic Liver Disease: A Case Report
by: Randy Adiwinata, et al.
Published: (2021-09-01)

Pain in Autosomal Dominant Polycystic Kidney Disease
by: Mariusz Niemczyk
Published: (2014-07-01)

GANAB and PKD1 Variations in a 12 Years Old Female Patient With Early Onset of Autosomal Dominant Polycystic Kidney Disease
by: Elizabeth Waldrop, et al.
Published: (2019-02-01)

Mouse models of polycystic kidney disease induced by defects of ciliary proteins
by: Je Yeong Ko, et al.
Published: (2013-02-01)

Efeitos colaterais cutâneos após uso prolongado de hidroxiuréia na Policitemia Vera Cutaneous effects after prolongaded use of hydroxyurea in Polycythemia Vera
by: Emmanuel Rodrigues de França, et al.
Published: (2011-08-01)

Results of kidney transplantation in patients with end-stage renal failure caused by autosomal dominant polycystic kidney disease
by: V. S. Daineko, et al.
Published: (2019-07-01)

Polycystic Liver Disease – Something to Consider in Case of an Acute Abdomen
by: Serghei Covantev, et al.
Published: (2021-01-01)

Clinical manifestations, imaging findings and laboratory abnormalities in 51 patients with autosomal dominant polycystic kidney disease: Experience at Tirupati, South India
by: K M Bhargav, et al.
Published: (2018-01-01)

Are you ready to accompany autosomal dominant polycystic kidney disease patients in their treatment journey? Real practice for selecting rapid progressors and treatment with tolvaptan
by: Yeonsoon Jung, et al.
Published: (2023-06-01)

Early Markers of Cardiovascular Risk in Autosomal Dominant Polycystic Kidney Disease
by: Silvia Lai, et al.
Published: (2017-12-01)

Outcome of renal transplantation from a donor with polycystic kidney disease
by: Silvia Regina da Cruz Migone, et al.

Tolvaptan in Pediatric Autosomal Dominant Polycystic Kidney Disease: From Here to Where?
by: Fei Liu, et al.
Published: (2021-07-01)

Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease
by: Yaerim Kim, et al.
Published: (2023-05-01)

Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report
by: Kyohei Kunizawa, et al.
Published: (2018-03-01)